Initial Beneficial Ownership · 3
Veradermics, Incorporated
MANENYSEEQUITYCurrent
Initial Beneficial Ownership
Structured filing — 3
wk-form3_1787267079.xml
Filing details
- Report period
- 2026-08-10
- Issuer
- Veradermics, Inc
- Issuer CIK
- 0001827635
- Trading symbol
- MANE
- No securities owned
- Checked
Reporting owner 1
- Name
- Hollander David
- Reporting owner CIK
- 0001793796
- Relationship
- Officer
- Officer title
- Chief R&D Officer
- Address
- 470 JAMES ST., NEW HAVEN, CT, 06513
Remarks
Exhibit List: Exhibit 24 - Power of Attorney
Signature 1
- Signed
- /s/ Michael Greco, Attorney-in-Fact
- Date
- 2026-08-20
Filed exhibits
- EX-24 ↗veradermicsdavidhollanderp.htm
Company context
We are a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Our initial focus is developing better treatments for pattern hair loss, or PHL, a condition affecting approximately 50 million men and 30 million women in the United States. Current PHL treatment options are limited and therefore are consistently plagued with high rates of treatment failure, patient dissatisfaction and treatment discontinuation. Patients and healthcare providers routinely identify the following shortcomings with currently available treatment options: